|
業務類別
|
-- |
|
業務概覽
|
Akeso Inc is an investment holding company. The Company's subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company has developed more than 50 drug candidates, including 15 bispecific antibody/multispecific antibody/bispecific antibody ADC/ADC/TCE drugs, with 27 drugs in clinical development. The majority of the company's revenue is derived from Mainland China, and it also has its presence in the USA and Other regions. |
| 公司地址
| No. 6, Shennong Road, Torch Development Zone, Guangdong Province, Zhongshan, CHN, 528437 |
| 電話號碼
| +86 76089873998 |
| 傳真號碼
| +86 76089873900 |
| 公司網頁
| https://www.akesobio.com |
| 員工數量
| 3035 |
| Dr. Peng Zhang |
Director and Senior Vice President |
-- |
29/04/2025 |
| Dr. Yu Xia |
Chairman of the Board, President and Chief Executive Officer |
-- |
29/04/2025 |
| Dr. Baiyong Li |
Director, Vice President and Chief Scientific Officer |
-- |
29/04/2025 |
| Dr. Zhongmin Maxwell Wang |
Director and Senior Vice President |
-- |
29/04/2025 |
|
|
| Mr. Bo Tan |
Independent Director |
29/04/2025 |
| Dr. Peng Zhang |
Director and Senior Vice President |
29/04/2025 |
| Mr. Ronggang Xie |
Director |
29/04/2025 |
| Dr. Yu Xia |
Chairman of the Board, President and Chief Executive Officer |
29/04/2025 |
| Dr. Baiyong Li |
Director, Vice President and Chief Scientific Officer |
29/04/2025 |
| Dr. Zhongmin Maxwell Wang |
Director and Senior Vice President |
29/04/2025 |
| Dr. Junwen Zeng |
Independent Director |
29/04/2025 |
| Dr. Yan Xu |
Independent Director |
29/04/2025 |
|
|
|
|
